Pitman Jama 4
4 · Deciphera Pharmaceuticals, Inc. · Filed Oct 31, 2023
Insider Transaction Report
Form 4
Pitman Jama
SVP, Regulatory & Quality
Transactions
- Award
Common Stock
2023-10-28+5,576→ 49,690 total - Sale
Common Stock
2023-10-30$12.02/sh−1,407$16,909→ 48,283 total
Footnotes (3)
- [F1]On February 15, 2023, the Reporting Person was granted restricted stock units ("RSUs"), which vest upon the satisfaction of three performance criteria. On October 28, 2023, the Issuer's Compensation Committee confirmed that performance criteria two had been met, resulting in the vesting of 5,576 RSUs.
- [F2]Includes 302 shares previously acquired under the Issuer's 2017 Employee Stock Purchase Plan.
- [F3]This sale was to cover tax liabilities in the vesting of RSUs.